治疗口腔溃疡的双层膜复方制剂的研制

王斌;钟明康;施孝金

中国药学杂志 ›› 2009, Vol. 44 ›› Issue (04) : 274-277.

中国药学杂志 ›› 2009, Vol. 44 ›› Issue (04) : 274-277.
论著

治疗口腔溃疡的双层膜复方制剂的研制

  • 王斌;钟明康;施孝金
作者信息 +

Study on a Double-layer Drug Films Used as Treating Recurrent Oral Ulcer

  • WANG Bin,ZHONG Ming-kang,SHI Xiao-jin
Author information +
文章历史 +

摘要

目的研制剂型更适合治疗口腔溃疡的双层膜药物制剂。方法通过预实验和正交实验,筛选出空白隔离层和药物层膜剂处方,用匀浆流延成膜法制成双层膜剂并进行相关指标的测定。结果以2.5%乙基纤维素乙醇液作为空白隔离层成膜液、以1%壳聚糖、2%明胶、pH6.5的水溶液作为药物层成膜液制成的双层膜剂,外观性状良好,空白隔离层无生物黏附性,不溶于唾液,能保护药物层药物不受唾液影响,使药物单侧释放,膜其他相关指标的测定结果符合临床需要。结论本实验研制的双层膜制剂结构合理、质量可控、适合口腔溃疡的局部治疗。

Abstract

OBJECTIVE To develop a double-layer drug films for treating recurrent oral ulcer. METHODS According to the pre-researches and orthogonal experiment,the optimal formulas of drug layer and sealing-coat layer were screened,then the double-layer drug films were prepared and the relevant parameters were measured. RESULTS The prepared double-layer drug films with 2.5% ethylcellulose ethanol solution as the sealing-coat layer solution and 1% chitosan,2% gelatin water solution (pH 6.5) as the drug layer solution showed good appearance .The drug layer obtained appropriate adherence time on mouth mucosa. The sealing-coat layer had no adherence and no dissolutionin in saliva. CONCLUSION The preparation has a reasonable structure and is suitable for treating Recurrent Oral Ulcer.

关键词

口腔溃疡 / 双层膜 / 壳聚糖 / 正交实验 / 口腔释药量

Key words

recurrent oral ulcer / double-layer films / chitosan / orthogonal experiment / release

引用本文

导出引用
王斌;钟明康;施孝金. 治疗口腔溃疡的双层膜复方制剂的研制[J]. 中国药学杂志, 2009, 44(04): 274-277
WNG in;ZHONG Ming-kng;SHI Xio-jin. Study on a Double-layer Drug Films Used as Treating Recurrent Oral Ulcer [J]. Chinese Pharmaceutical Journal, 2009, 44(04): 274-277

参考文献

[1] TAN B C.The progress in topical treatment of the recrudescent oral ulcer [J]. Int J Stomatology(国外医学口腔医学分册),2000,30(4):330-332. [2] KEIKO Y,TOSHIHISA Y,TOMOMITSU O. Pain relief of oral ulcer by dibucaine-film[J]. Pain,1999,83:625-626. [3] HOU N,ZHI Q. The progress in drug films used as treating oral ulcer [J]. Shandong Med Ind(山东医药工业),2002,21(5):17-19. [4] Ch.P(2005)Vol(中国药典2005年版.一部)[S].2005:AppendixⅠM [5] LIU H,WANG C L. Drug delivery system of oral mucosa and its quality evaluation [J]. Drug Eval,2004,1(2):132-135. [6] LU B. The New formulation and technology of medicine(药物新剂型与新技术)[M]. Beijing:People′s Medical Publishing House,2004,437. [7] HOU H M,WU Z M,HE F,et al. The study on sustained released preparation sticked on the oral mucosa[J]. Chin J Med Ind(中国医药工业杂志),1989,20(7):319-324 [8] ZHU S S. The New Dosage Form of Medicine(药物新剂型)[M]. Beijing:Chemical Industry Press,2003:251. [9] ZHOU Y. The study on the formulation design and clinical efficacy of the preparation treating oral ulcer [J]. J Med Theory Pract(医学理论与实践),2001,14(18):736-737. [10] ZHANG Y. The application on the medical area of the chitosan and its derivate[J]. Yunnan J Tradit Chin Med(云南中医中药杂志),2005,26(1):47-48. [11] AKSUNGUR P,SUNGUR A,UNAL S,et al. Chitosan delivery systems for the treatment of oral mucositis:in vitro and in vivo studies[J]. J Controlled Release,2004,98(2):269-279. [12] LI C P,JIANG S E. The Study on a Tinidazole compound films used as treating oral ulcer [J]. Her Med(医药导报),2004,23(4):255-256.

Accesses

Citation

Detail

段落导航
相关文章

/